Zenith Technologies' automation expertise will help biopharmaceutical manufacturers to improve their product quality, productivity and efficiency.
Cytiva has completed a strategic minority investment in Irish-owned Zenith Technologies, a leading technology company delivering manufacturing software systems and solutions for the life sciences industry. This enhancement of the existing partnership brings Zenith’s automation expertise to Cytiva’s customers, helping biopharmaceutical manufacturers to improve their product quality, productivity and efficiency. The investment also brings increased automation capability to the heart of new product development at Cytiva.
Zenith delivers automation management and process integration to its globally diverse customer base, supporting the process and technology choices that each customer makes, from consultancy, systems integration to managed services.
“Zenith has grown significantly over the last number of years and now has over 700 people globally. Zenith are engaged with the top 10 life science companies and we are looking forward to continuing to work with Cytiva and the next-generation of manufacturing solutions. This investment by Cytiva will further enhance our recent partnership and collaboration, and will enable an acceleration of growth for Zenith,” said Brendan O'Regan, Executive Chairman and Founder, Zenith Technologies.
Automation replaces many manual operations in today’s biopharmaceutical production and it plays a central role in manufacturing coordination, control, and documentation. Batch-to-batch consistency, and continuous monitoring, are enhanced through application of automation practices.To read the full announcement, click here.